You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方達控股(01521.HK)擬收購Nucro及Nucro Holdings的100%股權 代價約4.1億港元
格隆匯 08-16 06:20

格隆匯8月16日丨方達控股(01521.HK)發佈公吿,2023年8月15日(紐約時間),買方(公司間接全資附屬公司)及擔保人(公司全資附屬公司及買方母公司)與賣方、賣方代表、Nucro及Nucro Holdings就收購事項訂立購股協議,據此,賣方同意出售且買方同意購買目標公司合共100%股權,現金代價為7000萬加元(相當於約4.1億港元)並可根據該協議的條款及條件作出其中所載的作出調整。

目標公司Nucro Technics Inc.為一家於2004年2月1日根據加拿大法律成立的公司,其為醫療器械公司以及專門從事藥物發現和開發活動的生物製藥公司提供化學檢測、毒理學檢測、諮詢、研究及實驗室服務。 Nucro-Technics Holdings, Inc.為一家於2007年7月9日根據加拿大法律成立的公司。除持有 Nucro股份外,Nucro Holdings自成立以來並無經營業務。

公吿表示,收購事項將擴大集團在生物分析服務、毒理學服務及其他輔助藥物發現和開發服務的能力,並將增強集團通過其他科學家、設備及設施提供該等服務的能力。因此,董事會認為收購事項可能擴大集團的收益基礎,並強化集團作為合同研究機構行業全球領導者的地位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account